The 2027 National March for Life theme is “The Truth is Pro-Life,” the March for Life Education and Defense Fund announced Sept. 29.
The 2027 National March for Life theme is “The Truth is Pro-Life,” the March for Life Education and Defense Fund announced Sept. 29.
The third time’s a charm for Connor Whiffin. After not placing two years in a row, the Long Beach Catholic Regional School eighth grader was one of four winners of the school’s essay competition, the Pro-Life Oratory Contest. He wrote on why life in the womb is sacred and how to value human life.
Undaunted by high abortion rates in the United States, as well as a new state law that allows assisted suicide, pro-life supporters gathered for the diocese’s annual Pro Vita Mass on April 26 to reaffirm their commitment to preserving life.
About 100 people gathered on the campus of the University of Notre Dame Feb. 27 for an early evening event that organizers had been calling their “March on the Dome” just the day before.
A professor at the University of Notre Dame has declined a research appointment at the school, following weeks of outcry from students, staff and several U.S. Catholic bishops, over her prominent advocacy for abortion.
As the pro-life newspaper, The Tablet is showcasing stories of choosing life — from all walks of life — in this special section.
In a sudden development in a case that has lingered in the courts for nearly a decade, the state of New York has given up on trying to enforce an insurance regulation that would have forced Catholic and other religious organizations to pay for abortions.
As the pro-life movement prepares for the 53rd annual March for Life, their cause faces a number of key issues such as preserving the Hyde Amendment, the recent approval of a new generic abortion drug and a rising abortion rate.
When former Tablet journalist Melissa Enaje Rappa learned her unborn daughter had a rare genetic condition in early 2024, doctors warned the baby might not survive. Instead of giving up hope, she chose to trust in God’s plan.
The Food and Drug Administration recently approved a new generic form of mifepristone – a pill commonly, but not exclusively, used for early abortion – drawing criticism from pro-life advocates. It marks the second time a Trump administration has approved a generic form of the pill.